1. Schneider JW, Sanderson M, Geiger D, Nokta M, Silver S. A biobank to support HIV malignancy research for sub-Saharan Africa. In: South African Medical Journal (SAMJ). 2016/09/08 ed; 2016. pp. 867-869.

2. Rimsza L, Jaramillo MA, Kendrick S, Chadburn A, Heaton R, Glinsmann-Gibson B, et al. Cell of origin classification of human immunodeficiency virus positive vs negative diffuse large B cell lymphomas. In: 2016 ASH Meeting on Lymphoma Biology Colorado Springs, CO; 2016.

3. Zhang RZ, Cope FO, Lamers SL, Rose R, Nolan DJ, Salemi M, et al. The CD206 Macrophage Mannose Receptor acts a localization portal for targeting tumor cells and associated macrophages in HIV associated Kaposi’s sarcoma. In: 8th IAS Conference on HIV Pathogenesis Treatment and Prevention. Vancouver, Canada; 2015.

4. Barbachano-Guerrero A, Ayers LW, Martin JN, Rochford R, King CA. HIV-associated kaposi sarcoma is characterized by mast cell activation that reflects as elevated plasma levels of tryptase and histamine. In: 15th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, Maryland 2015.

5. Ayers LW, King CA. Mast Cells Effect Kaposi’s Sarcoma lesion modeling through differential Type 1 and Type VI collagen deposition. In: 10th AORTIC International Cancer Conference. Marrakech, Morocco; 2015.

6. McGrath MS, Bracci P, Cope F, Zhang RZ. Kaposi’s sarcoma represents a dynamic pathogenic process involving ongoing macrophage replenishment with both tumor cells as well as macrophages expressing CD206, a target for the recently approved imaging agent, Tilmanocept. In: American Association for Cancer Research (AACR) 105th Annual Meeting. San Diego, CA; 2014.

7. Loftin C, Heaton R, Rimsza L, Schmelz M. Reducing cost, energy, and space consumption for biological sample storage: A collaborative student pilot project between the colleges of medicine and engineering. In: International Society for Biological and Environmental Repositores (ISBER) 2014 Annual Meeting and Exhibits. Orlando, FL; 2014.

8. McGrath MS, Huyenstruyt LC, Zhang RZ. Tilmanocept, a labeled ligand for macrophage mannose receptor (CD206) may allow imaging of Kaposi’s sarcoma spindle cells and tumor associated macrophages. In: 14th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2013.

9. McGrath MS, Bracci P, Garcia DL, Huyenstruyt LC, Patel A, Ayers LW, et al. Optimal use of rare AIDS associated cancer specimens by the ACSR. In: International Society for Biological and Environmental Repositories (ISBER) 2013 Annual Meeting and Exhibits. Sydney, Australia; 2013.

10. Korir A, Mauti N, Moats P, Gurka MJ, Mutuma G, Metheny C, et al. Developing clinical strength-of-evidence approach to define HIV-associated malignancies for cancer registration in Kenya. In: 14th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, Maryland; 2013.

11. King CA, Ayers LW, Nohle DG, Kellough DA, Rochford R. Mast cells in kaposi’s sarcoma – A model for the pathogenesis of KSHV-driven oncogenesis. In: 14th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, Maryland; 2013.

12. King CA, Ayers LW, Nohle DG, Kellough DA, Rochford R. Kaposi’s sarcoma tumor evolution is characterized by mast cell-driven wound remodeling. In: 14th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, Maryland; 2013.

13. Huyenstruyt LC, Cu N, Honrada R, Garcia DL, Hunt PW, Martin JN, et al. Viability study of PBMC specimens shipped from Africa to the United States (US) in liquid nitrogen vapor shippers In: 14th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2013.

14. McGrath MS, Jin X, Burdo T, Williams K. Macrophage targeted therapy for AIDS: Regulation of monocyte differentiation with PA300, a novel oral form of MGBG that reverses CNS disease in a SIV model. In: 14th Annual International Meeting of the Institute of Human Virology (IHV). Baltimore, Maryland; 2012.

15. McGrath MS, Jin X, Burdo T, Williams K. Macrophage targeted therapy for AIDS: Regulation of monocyte differentiation with PA300, a novel oral form of MGBG that reverses CNS disease in a SIV model. In: XIX International AIDS Conference. Washington D.C; 2012.

16. Zhang RZ, Gascon G, Harris W, Katz J, Forshew D, Miller R, McGrath MS. Evaluation of Th1/Th2 lymphocyte balance and macrophage scavenger receptor expression in sporadic amyotrophic lateral sclerosis (sALS). In: 23rd International Symposium on ALS/MND. Chicago, Illinois; 2012.

17. Perner Y, Stevens W, Ayabomi EA, Adebamowo C, Chumba DK, Illiyasu Y, et al. EBV+ Plasmacytoma (PC) and plasmablastic lymphoma (PBL): HIV/AIDS-related extramedullary plasma cell proliferative disorders (PCPD) in Sub-Saharan Africa (Poster) In: International Academy of Pathology (IAP) Congress. Cape Town, South Africa; 2012.

18. Patel AA, Ayers LW, Bracci PM, Garcia DL, Gupta R, Silver S, et al. Implementing new technologies and data migration of existing data at a multi-site biobank: The AIDS and Cancer Specimen Resource experience. In: International Society for Biological and Environmental Repositories (ISBER) 2012 Annual Meeting and Exhibits. Westin Bayshore Hotel, Vancouver, British Columbia, Canada; 2012.

19. Patel AA, Ayers LW, Bracci PM, Garcia DL, Gupta R, Silver S, et al. Informatics solutions for management of unique specimen collections at a multi-site biobank: The AIDS and Cancer Specimen Resource experience. In: 2012 Annual Biospecimen Research Network Symposium (BRN). Bethesda, MD: Biospecimen Research Network Symposium; 2012.

20. NDung’u JR, Tumwine LK, Chumba DK, Lukande R, Ayers LW. Non-Hodgkin’s lymphomas in EAST Sub-Saharan Africa: report of the Sub-Saharan Africa lymphoma consortium (SSALC). In: 2012 International Academy of Pathology (IAP) Congress. Cape Town, South Africa; 2012.

21. Lamers SL, Fogel GB, Huysentruyt LC, McGrath MS. In vivo identification of dual-tropic HIV in the brain reservoir using a novel artificial neural network. In: XIX International AIDS Conference Washington D.C.; 2012.

22. Illiyasu Y, Adebamowo C, Ukah CO, Osuagwu CC, Enwere OO, Anyawu SC, et al. Malignant lymphomas in Nigeria: report of the WEST Sub-Saharan Africa lymphoma consortium (SSALC) (Poster) In: International Academy of Pathology (IAP) Congress. Cape Town, South Africa; 2012.

23. Huysentruyt LC, Lamers SL, McGrath MS. The prevalence of HIV-1 DNA in AIDS-related lymphoma and Kaposi Sarcoma throughout the AIDS epidemic. In: 13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD: Infectious Agents and Cancer; 2012. pp. 43.

24. Ayers LW, Abayomi EA, Adebamowo C, Chumba DK, Iliyasu Y, Naresh KN, et al. HIV/AIDS-related non-Hodgkin’s lymphomas and confounders: preliminary report of the Sub-Saharan Africa Lymphoma Consortium (SSALC). Infectious Agents and Cancer 2012,7:1-2.

25. Ayers LW, Abayomi EA, Adebamowo C, Chumba DK, Iliyasu Y, Naresh KN, et al. HIV/AIDS-related non-Hodgkin’s lymphomas and confounders: Preliminary report of the Sub-Saharan Africa Lymphoma Consortium (SSALC). In: 13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2012.

26. Abayomi EA, Maartens D, Stevens W, Perner Y, Ayers LW. Non-Hodgkin’s lymphomas in South Sub-Saharan Africa: report of the Sub-Saharan Africa lymphoma consortium (SSALC). In: 2012 International Academy of Pathology (IAP) Congress. Cape Town, South Africa; 2012.

27. Silver S, Mesri EA, Chadburn A, Cesarman E, Ashlock B, Ayers LW, et al. AIDS Epidemic Studies Require Access to Multicenter Biorepository Programs for Comparative Data. In: International Society for Biological and Environmental Repositories (ISBER) 2011 Annual Meeting and Exhibits: Impact and Public Benefits of Biorepositories Arlington, Virginia (Washington DC) Biopreservation and Biobanking (BIO) – ISBER; 2011. pp. 72-114.

28. Lukande R, Tumwine LK, Rogena EA, NDung’u JR, Ayers LW. Global collaboration for HIV/AIDS cancer related research: Establishing AIDS & Cancer Specimen Resource biorepositories in East Africa. In: International Society for Biological and Environmental Repositories (ISBER) 2011 Annual Meeting and Exhibits: Impact and Public Benefits of Biorepositories Arlington, Virginia (Washington DC) Biopreservation and Biobanking (BIO) – ISBER; 2011. pp. 72-114.

29. Ayers LW, Abayomi A, Adebamowo C, Chumba DK, Iliyasu Y, Naresh KN, NDung’u JR, Stevens W, Tumwine L. AIDS-related malignant lymphoma subtype characteristics in South, East and West Sub-Saharan Africa: Report of the Sub-Saharan Africa Lymphoma Consortium (SSALC/NCI). In: 2011 AORTIC Conference. Cairo, Egypt; 2011.

30. Huysentruyt LC, Lamers SL, McGrath MS. The prevalence of HIV-1 DNA in AIDS-related lymphoma and Kaposi Sarcoma throughout the AIDS epidemic. In: 13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, Maryland; 2011.

31. Huysentruyt LC, Bracci PM, McGrath MS. MM. High HIV-1 DNA copy number defines a unique subset of AIDS related lymphoma. In: American Association for Cancer Research (AACR) 102nd Annual Meeting. Orlando, Florida; 2011.

32. Ayers LW, Tumwine L, Perner Y. Tissue quality continues as significant obstruction to international comparison of tumor subtypes using biomarkers: lymphoma classification by the Sub-Saharan Africa Lymphoma Consortium. . In: 2011 Annual Biospecimen Research Network Symposium (BRN). Bethesda, MD 2011.

33. Ayers LW, Lukande R, NDung’u JR, Chumba DK, Tumwine LK. Multicentric Castlemen’s Disease (MCD) and Other Related KSHV Lymphoproliferations in East Africa. In: 13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, Maryland; 2011.

34. Wiley DJ, Masongsong EV, Barman P, Elashoff DA, Coutlée F, Group HS. Cytosine methylation in the HPV16 3’ L1/ 5’LCR region characterized from anal epithelia of HPV-HIV co-infected men. In: 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2010.

35. Tumwine LK, Lukande R, Zhao W, Ayers LW. Immunohistochemically confirmed HHV-8-related lymphoproliferative disorders in Uganda. In: 10th Biennial Conference of the Association of Pathologists of East, Central and Southern Africa (APECSA). Kampala, Uganda; 2010.

36. Tumwine LK, Lukande R, Zhao W, Ayers LW. Immunohistochemically confirmed HHV-8-related lymphoproliferative disorders in Uganda. In: 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2010.

37. Silver S, Ayers LW, Senyak J, Bracci PB, Garcia DL, McGrath MS. The AIDS and Cancer Specimen Resource’s audit checklist tool for assuring multisite member compliance with best practices for biorepositories. In: International Society for Biological and Environmental Repositories (ISBER) 2010 Annual Meeting and Exhibits. Rotterdam, Netherlands; 2010.

38. Lee GQ, Kigozi I, Bangsberg D, Emenyonu N, Bennett J, Hunt P, et al. Prevalence and virologic consequences of transmitted drug resistance mutations in Uganda In: 17th Conference on Retroviruses and Opportunistic Infections (CROI 2010). San Francisco, CA; 2010.

39. Lamers SL, McGrath MS. The ACSR: a resource for bioinformatic studies on HIV infection and associated disease processes. In: International Society for Biological and Environmental Repositories (ISBER) 2010 Annual Meeting and Exhibits. Rotterdam, Netherlands; 2010.

40. Lamers SL, Fogel G, Poon AF, McGrath MS. Disease-specific protein structures in HIV. In: Keystone Symposia on Molecular and Cellular Biology: Structural Biology. Breckenridge, CO; 2010.

41. Lamers SL, Fogel G, Huysentruyt LC, Poon AF, McGrath MS. The HIV nef protein within ARL is genetically and structurally distinct from those in the brain of patients with HAD In: 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2010.

42. Iliyasu Y, Zhao W, Ayers LW. Malignant lymphoma subgroups from Zaria, Nigeria reveal absence of HIV/AIDS related plasmablastic lymphomas and HHV-8 related lymphoproliferative disorders. In: 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2010.

43. Iliyasu Y, Ayers LW. Epstein-Barr virus association with malignant lymphoma subgroups in Zaria, Nigeria. In: 10th Biennial Conference of the Association of Pathologists of East, Central and Southern Africa (APECSA). Kampala, Uganda. ; 2010.

44. Huysentruyt LC, McGrath MS. Identification of a subset of AIDS related lymphoma (ARL) containing HIV infected macrophages that is immunophenotypically distinct from EBV positive ARL. In: American Association for Cancer Research (AACR) 101st Annual Meeting. Washington, DC; 2010.

45. Ayers LW, Lukande R, Tumwine LK. Diagnosis of HIV-related malignancies in resource-constrained settings of sub-Saharan Africa, a cautionary tale for non-Hodgkin’s lymphoma. In: 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2010.

46. Ayers LW. The Sub-Saharan Africa Lymphoma Consortium (SSALC): Johannesburg report. In: Charlotte Maxeke Johannesburg Academic Hospital presentation. Johannesburg, South Africa; 2010.

47. Ayers LW. The Sub-Saharan Africa Lymphoma Consortium (SSALC): South Africa report. In: Federation of South African Pathology Societies Annual Congress. Cape Town, South Africa; 2010.

48. Ayers LW. Banking AIDS-related malignancies in sub-Saharan Africa. In: 2010 Annual Biospecimen Research Network Symposium (BRN). Bethesda, MD; 2010.

49. Abayomi EA, Sommers A, Grewal R, Sissolak G, Bassa F, Maartens D, et al. Malignant lymphoma incidence and HIV-related lymphoma subtypes in the Western Cape of South Africa, 2002-2009. In: Federation of South African Pathology Societies Annual Congress. Cape Town, South Africa; 2010.

50. Abayomi EA, Sommers A, Grewal R, Sissolak G, Bassa F, Maartens D, et al. Malignant lymphoma incidence and HIV-related lymphoma subtypes in the Western Cape of South Africa, 2002-2009. In: 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2010.

51. McGrath MS, Salemi M, Gray R, Huysentruyt LC, Lamers SL. Phylodynamic analysis of macrophage associated HIV-1 gp120 during AIDS associated lymphomagenesis suggests the existence of unique tumor associated HIV In: 7th International Worshop on HIV, Cells of Macrophage/Dendritic Lineage and Other Reservoirs. Colombaro di Corte Franca, Italy; 2009.

52. McGrath MS, Huysentruyt LC, Lamers SL, Salemi M, Silver S, Chadburn A, Garcia DL, Ayers LW. AIDS lymphoma as a model system for studying the role of macrophages in the pathogenesis of cancer. In: 2009 National Cancer Institute (NCI) Translational Science Meeting (TSM2). Vienna, VA.; 2009.

53. Zhang R, Gascon R, Miller RG, Champion S, Katz J, Honrada R, Lancero M, Narvaez A, McGrath MS. Macrophage activity marker soluble CD14 is increased in plasma of patients with sporadic Amyotrophic Lateral Sclerosis (sALS). In: 20th International Symposium on ALS/MND Berlin; 2009.

54. McGrath MS, Silver S, Orenstein JM, Huysentruyt LC, Chadburn A, Cesarman E, et al. Optimal use of limited resource tissues for AIDS related cancer research. In: International Society for Biological and Environmental Repositories (ISBER) 2009 Annual Meeting and Exhibits. Portland, OR; 2009.

55. Lamers SL, Fogel G, Poon AF, McGrath MS. Identification of HIV-1 nef sequences associated with the development of dementia. In: 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Cape Town, South Africa; 2009. pp. July 19-22, 2009.

56. Huysentruyt LC, Lamers SL, Salemi R, Gray R, Fogel G, McGrath MS. A phylodynamic view of varied AIDS-associated neuropathologies. In: 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Cape Town, South Africa; 2009. pp. July 19-22, 2009.

57. Chadburn A, Silver S, Pasqaulucci L, Dalla-Favera R, Merati K, McGrath MS, et al. Comparison of AIDS-related diffuse large B-cell lymphomas (AR-DLBCLs) and immunocompetent (IC) DLBCLs suggest biologic differences. In: United States and Canadian Academy of Pathology (USCAP 2009) 98th Annual Meeting. Boston, MA; 2009.

58. Chadburn A, Silver S, Pasqaulucci L, Dalla-Favera R, Merati K, McGrath MS, et al. Comparison of AIDS-related diffuse large B-cell lymphomas (AR-DLBCLs) and immunocompetent (IC) DLBCLs suggest biologic differences. In: 16th Conference on Retroviruses and Opportunistic Infections (CROI 2009). Montreal, Canada; 2009.

59. Ayers LW, Tumwine LK. Sub-Saharan Africa Lymphoma Consortium (SSALC): understanding lymphoma phenotypes in Africa; building capacity for future treatments. In: NCI Symposium on Chromosome Biology: Cancer and HIV Workshop. Bethesda, MD; 2009.

60. Zhang RZ, Gascon G, Miller RG, Gelinas DF, Mass J, Lancero L, et al. MCP-1 chemokine receptor CCR2 Is decreased on circulating monocytes in sporadic ALS. In: 19th International Symposium on ALS/MND. Birmingham, UK; 2008.

61. Widney DP, Gui D, Said JW, Breen EC, Detels R, Martínez-Maza O. Expression and function of the chemokine, CXCL13, and its receptor, CXCR5, in AIDS-associated non-Hodgkin’s lymphoma. In: 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2008.

62. McGrath MS, Wongkham S, Subimerb C. Activated blood macrophages in cholangiocarcinoma patients are highest in those with tumors containing recent blood derived mac387+ macrophage migrants. In: American Association for Cancer Research (AACR) 99th Annual Meeting:. San Diego, CA; 2008.

63. McGrath MS. Genetically restricted HIV-1 sub populations are associated with and migrate within metastatic sites of AIDS related lymphoma. . In: 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2008.

64. Lamers SL, Salemi M, Granier SC, de Oliveira T, Galligan D, McGrath MS. Recombination rates are higher in tissues showing significant macrophage infiltration and vary among ENV, NEF and LTR domains In: XVII International AIDS Conference (IAS). Mexico City, Mexico; 2008.

65. Ayers LW, Dominguez G, Bhatia K. Evaluation of Epstein-Barr (EBV) and human herpes virus-8 (HHV-8) in HIV-associated persistent generalized lymphomadenopathy (PGL). In: 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2008.

66. Alcendor DJ, Zhu WQ, Desai P, Hayward GS. Suppression of Galectin-3 in KSHV infected DMVEC cells and Kaposi’s sarcoma: implications for tumorigenesis. In: 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2008.

67. Silver S, Garcia DL, Ayers LW, Orenstein JM, McGrath MS. The AIDS and cancer specimen resource: a biospecimen resource for studies on AIDS pathogenesis In: The 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention Sydney Australia; 2007.

68. Shagrun LS, Morris A, Behler C, McGrath MS. Macrophage levels in large cell lymphoma are associated with survival. In: American Society of Clinical Oncology (ASCO) 43rd Annual Meeting. Chicago, IL; 2007.

69. Salemi M, Galligan D, Lamers SL, de Oliveira T, Zhao L, McGrath MS. Extensive intra-patient recombination between and within HIV-1 env and nef genes sampled from different tissues. In: Conference on Retroviruses and Opportunistic Infections (CROI 2007). Los Angeles, CA; 2007.

70. Lamers SL, Zhao L, Salemi M, de Oliveira T, McGrath MS. HIV-1 genetic recombination rates vary dramatically between different tissue compartments. In: Keystone Symposia Global Health Series: Molecular and Cellular Determinants of HIV Pathogenesis. Whistler, British Columbia, Canada; 2007.

71. Galligan D, Lamers SL, Salemi M, de Oliveira T, Zhao L, Morris A, Shagrun L, McGrath MS. Non-random migration of macrophage tropic HIV-1 sequences between sites of AIDS lymphoma: Evidence for directional metastic spread. In: 14th International Workshop on HIV Dynamics and Evolution Paradore de Segovia in Segovia, Spain; 2007.

72. Zhang RZ, Miller RG, Gascon G, Gelinas DF, Katz J, Mass J, et al. Evidence for abnormal monocyte immunoglobulin receptor expression in sporadic amyotrophic lateral sclerosis (sALS). In: 17th International Symposium On ALS/MND Yokohama, Japan; 2006.

73. Subbiah V, Mwanda OW, Orem J, Fu P, Banura C, Kakembo J, et al. Analyses of prognostic factors for survival in East African patients with AIDS-related non-Hodgkin’s Lymphoma (AR-NHL) treated with dose modified oral chemotherapy. In: 10th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). North Bethesda, MD; 2006. pp. AB#50.

74. Shagrun LS, Morris A, McGrath MS. “Promacs” in cases of HIV+ and HIV- large cell lymphoma. In: 10th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). North Bethesda, MD; 2006.

75. Orem J, Mwanda OW, Fu P, Banura C, Kakembo J, Ness A, et al. Implications of oral chemotherapy for AIDS-related non-Hodgkin’s lymphoma (AR-NHL). In: 10th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). North Bethesda, MD; 2006. pp. AB#51.

76. Nohle DG, Ayers LW. Extending the API TMA data exchange specification to single specimen and cutting edge matrix assembly (CEMA). In: ASIP INFORMATICS, Experimental Biology 2006: Advancing the Biomedical Frontier. The Moscone Convention Center, San Francisco, CA; 2006.

77. Mwanda OW, Orem J, Fu P, Banura C, Kakembo J, Ness A, et al. Dose modified oral chemotherapy for AIDS-related non-Hodgkin’s Lymphoma (AR-NHL) in East Africa. In: 10th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). North Bethesda, MD; 2006. pp. 70.

78. Mwanda OW, Orem J, Fu P, Banura C, Kakembo J, Ness A, et al. Dose modified oral chemotherapy for AIDS-related non-Hodgkin’s Lymphoma (AR-NHL) in East Africa: Impact on CD4+ count and HIV-1 replication; and retrospective look at similar regimen in pre-HAART era in the USA. In: 10th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). North Bethesda, MD; 2006. pp. 36.

79. McGrath MS, Galligan D, Lamers SL, Salemi M. HIV infected macrophages associated with lymphoma (ARL) show distinct patterns of evolution in vivo. In: 13th Conference on Retroviruses and Opportunistic Infections (CROI 2006). Denver, CO; 2006.

80. Galligan D, Lamers SL, Zhao L, Yu S, Shagrun L, De Oliveria T, et al. Multi-site tissue autopsy samples from patients with dementia and AIDS related lymphoma show distinct patterns of HIV evolution in vivo. In: XVI International AIDS Conference (IAS). Toronto, Canada; 2006.

81. Galligan D, Lamers SL, de Oliveira T, Salemi M, McGrath MS. HIV-1 molecular dynamics in multisite lymphoma biopsies. In: HIV Pathogenesis Symposium. Keystone, CO; 2006.

82. Bako J, Mwanda OW, Orem J, Fu P, Subbiah V, Banura C, et al. Comparative retrospective study of patients at diagnosis with AIDS-related non-Hodgkin’s Lymphoma (AR-NHL) treated with oral chemotherapy in the pre-HAART era in East Africa and the USA. In: 10th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). North Bethesda, MD; 2006. pp. AB#48.

83. Ayers LW, McGrath MS, Silver S, Orenstein JM, Bhatia K. The AIDS and Cancer Specimen Resource (ACSR) provides Kaposi’s sarcoma (KS) and non-Hodgkin’s lymphoma (NHL) specimens for translational research. In: 9th International Workshop on Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) and Related Agents. Cape Cod, MA; 2006.

84. Ayers LW, McGrath MS, Silver S, Orenstein JM, Bhatia K. RNA, DNA and molecular targets in archived paraffin-embedded tissue samples, 1980–2005. In: International Society for Biological and Environmental Repositories (ISBER) 2006 Annual Meeting. Bethesda, MD; 2006.

85. Ayers LW, Hackman BA, Nohle DG. Software-assisted image analysis for ACSR tissue microarays (TMA) quality control. In: International Society for Biological and Environmental Repositories (ISBER) 2006 Annual Meeting. Bethesda, MD; 2006.

86. Ayers LW, Hackman BA, McGrath MS, Silver S, Orenstein JM, Bhatia K. HIV/AIDS-related Lymphoma Immunophenotypes in Biopsy Samples from Patients During Pre and Post HAART Treatment Periods. In: 10th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). North Bethesda, MD; 2006.

87. Zhang RZ, Gascon G, Miller RG, Gelinas DF, Mass J, Lancero L, et al. MCP-1 chemokine receptor CCR2 is absent on circulating monocytes in sporadic ALS. In: 16th International Symposium on ALS/MND. Dublin, Ireland; 2005.

88. Yu S, Hadlock KG, Miller RG, Do H, Mass J, Zhang RZ, et al. Detection of ALS by quantitative real time RT-PCR of peripheral blood cells. In: 16th International Symposium on ALS/MND. Dublin, Ireland; 2005.

89. Silver S, Ayers LW, Orenstein JM, McGrath MS. The AIDS and Cancer Specimen Resource (ACSR) model for cancer research facilitation. In: International Society of Biological and Environmental Repositories (ISBER) 2005 Annual Meeting and Exhibits Bellevue, WA; 2005.

90. McGrath MS, Salemi M, Lamers SL. Genetic analysis of HIV in AIDS malignancies. In: 7th International Meeting of the Institute of Human Virology. Baltimore, MD; 2005.

91. McGrath MS, Lamers SL, Salemi M. HIV infected macrophages associated with dementia (HAD) and lymphoma (ARL) show distinct patterns of evolution in vivo. In: 6th International Workshop on HIV, Cells of Macrophage/Dendritic Lineage & Other Reservoirs. Varenna, Italy; 2005.

92. McGrath MS, Lamers SL, Salemi M. Evolutionary distinct forms of HIV in AIDS lymphoma and dementia. In: 9th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). North Bethesda, MD; 2005.

93. McGrath MS, Lamers SL, Salemi M. HIV sequence evolution in the brain: Distinctly different evolutionary pathways between HAD and primary CNS lymphoma associated strains of HIV. . In: 3rd IAS Conference on HIV Pathogenesis and Treatment. Rio de Janeiro, Brazil; 2005.

94. Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, et al. Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-cancer registry match study. , Marriott Bethesda North Hotel & Conference Center. In: 9th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). North Bethesda, MD; 2005.

95. Salemi M, Lamers SL, Yu S, de Oliveira T, Fitch WM, McGrath MS. Phylodynamic Analysis of HIV-1 in the Brain. In: 15th International HIV Dynamics and Evolution Cleveland, OH; 2005.

96. Levine AL, Seaberg EC, Hessol NA, Preston-Martin S, Li M, Silver S, et al. HIV is not a risk factor for lung cancer in women: data from the women’s interagency HIV study (WIHS). In: 9th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). North Bethesda, MD; 2005.

97. Lamers SL, Salemi M, McGrath MS. HIV-1 envelope domains derived from AIDS related lymphoma tissues display unique substitution patterns as compared to published envelope domains. . In: 3rd IAS Conference on HIV Pathogenesis and Treatment. Rio de Janeiro, Brazil; 2005.

98. Jin X, Hadlock K, Yu S, Do H, Miller RG, Mass J, et al. Mutational recovery of viral open reading frames in selected HERV-K-related endogenous retro viruses in ALS patients. In: 16th International Symposium on ALS/MND. Dublin, Ireland; 2005.

99. Huerta-Yepez S, Vega M, Gui D, Said J, Bonavida B. Analysis of YY1 and XIAP Expression, Proteins That Regulate Resistance, in AIDS-NHL Tissue Arrays. In: Blood – American Society of Hematology 47th Annual Meeting (ASH 2005). Atlanta, Georgia; 2005. pp. A1933.

100. Haidt S.J. , Gascon R., Zhang R., Stern W., Wieland M., Boldrey E., et al. Blood monocyte expression levels of HLA-DR and CD16 are markers of disease progression in Age Related Macular Degeneration (ARMD) In: Association for Research in Vision and Ophthalmology (ARVO). Fort Lauderdale, Florida; 2005.

101. Do H, Hadlock KG, Miller RG, Yu S, Mass J, Zhang RZ, et al. Transcriptional program of peripheral blood cells in ALS: evidence for systemic immune activation. In: 16th International Symposium on ALS/MND. Dublin, Ireland; 2005.

102. Dittmer DP, Staudt MR, Fakhari FD, Hilscher C, Sin S, Chaput A. Regulation of KSHV latent gene expression. In: 9th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). North Bethesda, MD; 2005.

103. Silver S, Ayers LW, Orenstein JM, McGrath MS. AIDS and Cancer Specimen Resource (ACSR): a resource for your research. In: International Society of Biological and Environmental Repositories (ISBER) 2004 Annual Meeting and Exhibits. Perugia, Italy; 2004.

104. Nohle DG, Hackman BA, Ayers LW. Tissue micro-array data TMA standard and public tool for linked legend and clinical details at http://acsr.mid-region.org. In: 8th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2004.

105. McGrath MS, Garcia DL, Ayers LW, Silver S, Orenstein JM, Lamers SL. AIDS and Cancer Specimen Resource: A resource for HIV reservoir research. In: XV International AIDS Conference (IAS). Bangkok, Thailand; 2004.

106. Ayers LW, Jin X, Bauer JA, McGrath MS. HIV integration sites found in cardiac myocyte nuclei and adjacent PCNA positive macrophage nuclei from AIDS cardiomopathy heart tissue. In: 8th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2004.

107. Jin X, Yu S, Green C, Weinstein M, Mack K, McGrath MS. HIV-associated dementia: High frequency HIV integration within introns suggest a role for insertional mutagenesis and disease pathogenesis. In: 2003 Institute of Human Virology (IHV). Baltimore, MD; 2003.

108. Silver S, Ayers LW, Orenstein JM, McGrath MS. AIDS and Cancer Specimen Resource: a resource for your research. In: International Society for Biological and Environmental Repositories (ISBER) 2003 Annual Meeting and Exhibits. Philadelphia, PA; 2003.

109. McGrath MS, Jin X, Yu S, Green C, Weinstein M, Mack KS. HIV integration within activation loci is characteristic of dominant insertion sites within the diseased tissues of patients with HIV associated dementia and AIDS related lymphoma. In: 1st International Workshop on HIV Persistence during Therapy. St Martin, French West Indies; 2003.

110. Ayers LW, Mihm MJ, Hackman BA, Bauer JA, (ACSR) MAaCSR. AIDS patients have high levels of protein nitration within actively HIV infected cells. Does this cause organ malfunction and cancer? In: 7th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2003.

111. McGrath MS, Jin X, Yu S, Wei R, Kapp L, Green C, et al. HIV insertions within and proximal to host cell genes are a common finding in tissues containing high levels of HIV DNA and macrophage associated P24 antigen expression. In: 5th International Workshop on HIV, Cells of Macrophage/Dendritic Lineage and Other Reservoirs Rome, Italy; 2002.

112. Garcia DL, McGrath MS, Silver S, Orenstein JM, Ayers LW. AIDS and Cancer Specimen Bank. In: XIV International AIDS Conference (IAS). Barcelona, Spain; 2002.

113. Garcia DL, Ayers LW, Axiotis C, Orenstein JM, Miles S, Silver S, et al. ACSB CODCC, AIDS and Cancer Specimen Bank: a resource for your research. In: 6th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2002.

114. Ayers LW, Romer DJ, Yi H, (ACSB) TMAaCSB. A tissue array management system (TAMS) for the AIDS Cancer and Specimen Bank (BANK) developed to manage numerical and digital image cancer research data from tissue microarrays (TMAs). In: 6th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI). Bethesda, MD; 2002.

115. Garcia DL, McGrath MS, Silver S, Miles S, Ayers LW, Axiotis C. AIDS and Cancer Specimen Bank. In: 5th International AIDS Malignancy Conference. Bethesda, MD; 2001.

116. McGrath MS, Elbaggari A, Gascon R, Herndier BG, Meuer S, Giese T, et al. Quantitation of AIDS lymphoma associated macrophage RNA. implications for “Sequential Pathogenesis” of extranodal lymphoma: Abstract 49. In: 4th International AIDS Malignancy Conference. Bethesda, MD; 2000.

117. Flickinger J, McGrath MS, Silver S, Orenstein JM, Miles S, Ayers LW, et al. Tissue and biological fluids banks of HIV-related malignancies: ABSTRACT 15. In: 4th International AIDS Malignancy Conference. Bethesda, MD 2000.

118. Ayers LW, Consortium TMA. Application of the tissue microarray (TMA) method by the Midregion AIDS and Cancer Specimen Bank (ACSB) to prepare study sets from HIV infected and control tissues: Abstract 16. In: 4th International AIDS Malignancy Conference. Bethesda, MD; 2000.

119. Abbey NW, Silver S, Orenstein JM, Miles S, Ayers LW, Axiotis C, et al. The AIDS and Cancer Specimen Bank. In: 4th International AIDS Malignancy Conference. Bethesda, MD; 2000.

120. Flickinger J, McGrath MS, Silver S, Orenstein JM, Miles S, Ayers LW, et al. Tissue and biological fluids banks of HIV-related malignancies: ABSTRACT 23. In: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology (J Acquir Immune Defic Syndr Hum Retrovirol); 1999. pp. A15.

121. Flickinger J, McGrath MS, Silver S, Orenstein JM, Miles S, Ayers LW, et al. AIDS malignancy bank: a source for tissue and biological fluids of HIV-related malignancies. In: 3rd National AIDS Malignancy Conference. Bethesda, MD; 1999.

122. Ayers LW, McGrath MS, Silver S, Miles S, Axiotis C. The AIDS and Cancer Specimen Bank (ACSB), a NCI tissue and biological fluids bank of HIV infected tissues. In: 3rd National AIDS Malignancy Conference. Bethesda, MD; 1999.

123. Mallery SR, Clark YM, Ness GM, Ayers LW, Hohl CM. AIDS-Kaposi’s Sarcoma cells demonstrate increased susceptibility to a redox cycling drug. In: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology (J Acquir Immune Defic Syndr Hum Retrovirol); 1998. pp. A18.

124. Mallery SR, Clark YM, Ness GM, Ayers LW, Hohl CM. AIDS-Kaposi’s sarcoma demonstrate increased susceptibility to a redox cycling drug. In: 2nd National AIDS Malignancy Conference. Bethesda, MD; 1998.

125. Mack KD, Wei R, Shiramizu B, Herndier BG, Elbeggari A, Gascon R, et al. Evidence for HIV mediated CIS-activation of the c-fes protooncongene in a subset of AIDS associated lymphomas. In: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology (J Acquir Immune Defic Syndr Hum Retrovirol); 1998. pp. A34.

126. Mack KD, Wei R, Shiramizu B, Herndier BG, Elbaggari A, Gascon R, et al. Evidence for HIV mediated cis-activation of the c-fes protooncogene in a subset of AIDS associated lymphomas. In: 2nd National AIDS Malignancy Conference. Bethesda, MD; 1998.

127. Flickinger J, Silver S, Orenstein JM, Miles S, Axiotis C, Ayers LW, et al. AIDS malignancy bank: a source for tissue and biological fluids of HIV-related malignancies. In: XII International AIDS Conference (IAS). Geneva, Switzerland; 1998.

128. Flickinger J, McGrath MS, Silver S, Orenstein JM, Miles S, Ayers LW. AIDS malignancy bank: a source for tissue and biological fluids of HIV-related malignancies. In: 2nd National AIDS Malignancy Conference. Bethesda, MD; 1998.

129. Flickinger J, McGrath MS, Silver S, Miles S, Ayers LW, Axiotis C. Tissue and biological fluids banks of HIV-related malignancies: ABSTRACT 50 In: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology (J Acquir Immune Defic Syndr Hum Retrovirol); 1998. pp. A24.